Generic, Branded and Biosimilar — Chemotherapy in India
The price gap between branded and generic chemotherapy medicines in India can be large enough to change decisions — but it does not reflect a difference in the medicine's active ingredient. This page explains what is the same, what is different, and what questions to ask.
- Same active molecule — A generic contains the same active ingredient as its branded original, approved by CDSCO to the same regulatory standard.
- The price gap is real — Generics are often significantly cheaper. The difference reflects manufacturing and marketing costs, not the medicine's effect on cancer.
- Biosimilars are different — Biological medicines cannot be copied molecule for molecule. A biosimilar must show clinical similarity, not just chemical equivalence.
- Quality can be checked — CDSCO approval, licensed supply chains and batch documentation are the markers to ask about before treatment.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026
A generic chemotherapy medicine contains the same active molecule as its branded equivalent and must meet the same regulatory standard under CDSCO rules. The price gap between them can be substantial, but it reflects manufacturing and marketing costs — not a difference in the medicine's ability to treat the cancer.
Is a generic chemotherapy the same as the branded version?
A generic chemotherapy medicine contains the same active pharmaceutical ingredient as the branded original, at the same strength and in the same form. For CDSCO approval, the manufacturer must demonstrate bioequivalence — that the medicine releases the active ingredient into the body in a comparable way to the reference product.
What differs is the trade name, the packaging, the inactive ingredients such as fillers and coatings, and the price. The chemistry that acts on the cancer cell is the same.
The word 'generic' does not mean inferior. It means the patent protecting the original molecule has expired, allowing other manufacturers to produce it. This is how the same medicine becomes available from multiple suppliers at different price points.
What you can check before a chemotherapy medicine is prepared
- Confirm the medicine name with your oncologist at every cycle, not just the first.
- Ask the dispensing team to show you the batch number, manufacturer name and expiry date on the pack.
- Check that the label carries a CDSCO approval number or valid import licence.
- If the packaging looks different from a previous cycle, tell the team and ask what changed before it is administered.
- If you have obtained any medicine from outside the treating facility, tell your oncologist before it is used.
Why is there such a large price gap between branded and generic chemotherapy?
The originator company spent years and large sums on research, clinical trials and regulatory approval. Patent protection gave them an exclusive period to recover those costs, typically at a higher price point.
Once the patent expires, other manufacturers can produce the same molecule. Competition between manufacturers brings prices down. In India, the National Pharmaceutical Pricing Authority (NPPA) also sets ceiling prices for many essential medicines, including some chemotherapy agents.
This is why the same active molecule can cost very different amounts depending on the manufacturer and the source. The difference is real and can be large. It does not reflect a difference in what the medicine does in the body.
Who chemotherapy is not suitable for
Chemotherapy in any form — generic, branded or biosimilar — is not given to everyone with cancer. Eligibility is decided by an oncologist for each individual case, based on tumour type, stage, general fitness, organ function and other active medical conditions.
- People with severely reduced kidney or liver function may not be able to clear certain chemotherapy agents safely.
- Those with very low blood counts or bone marrow not recovering adequately may not be suitable until counts improve.
- Patients who are pregnant or breastfeeding: most chemotherapy agents carry serious risks to the developing baby or infant.
- People with certain heart conditions, depending on the specific agent being considered.
- Those who have already received the maximum safe cumulative dose of a particular agent.
No chemotherapy should be started without a full oncology assessment.
What is a biosimilar, and why is it different from a generic?
Generics work for small-molecule medicines — simple chemicals that any qualified manufacturer can reproduce molecule for molecule. Biological medicines are different: they are large, complex proteins grown in living cells, and no two batches from any manufacturer are ever identical.
A biosimilar is a biological medicine shown to be highly similar to an approved reference biological product, with no clinically meaningful differences in safety or effect. CDSCO's biosimilar guidelines set out what data the manufacturer must provide to obtain approval.
Because of this complexity, biosimilars require more extensive testing than generics — including clinical data, not just a bioequivalence test. Your oncologist will know which biosimilars are approved for the specific biological medicine in your treatment plan.
Key terms on your prescription
- Active pharmaceutical ingredient (API)
- The molecule in the medicine that produces the therapeutic effect. A generic and its branded originator contain the same API.
- Generic
- A medicine containing the same API as the branded originator, manufactured after the patent expires and approved by CDSCO to the same regulatory standard.
- Branded originator
- The first version of a medicine, brought to market by the company that developed it under patent protection.
- Biosimilar
- A biological medicine shown to be highly similar to an already-approved reference biological product, with no clinically meaningful differences in safety or effect.
- Bioequivalence
- The test a generic must pass: demonstrating that it releases the active ingredient into the body comparably to the reference product.
- CDSCO
- Central Drugs Standard Control Organisation — India's national drug regulator, which approves all medicines for use in the country.
- NPPA
- National Pharmaceutical Pricing Authority — sets ceiling retail prices for essential medicines in India, including some chemotherapy agents.
Questions families ask about generic and biosimilar chemotherapy
Can I ask my oncologist to prescribe a specific brand?
Yes, and it is a reasonable question to raise. Your oncologist may have a preference based on their experience with a particular manufacturer's consistency. They may also work within a hospital formulary — a pre-approved list of medicines the facility uses. Raise the question before your first cycle, not after the medicine has been prepared. If you have concerns about a switch during treatment, say so to the team before the next cycle begins.
Does a lower price mean lower quality?
Not because of the price alone. CDSCO approval means the medicine has met a defined standard of quality, safety and bioequivalence. What varies between manufacturers is how reliably each batch meets that standard over time — this is a manufacturing consistency question, not a price question. Your treating team selects medicines from manufacturers with a consistent supply record. The price you pay reflects procurement, margins and supply-chain costs, not regulatory compliance.
What happens if the hospital switches brands during my treatment?
For most generic chemotherapy agents, switching between approved manufacturers does not change the clinical effect, because the active molecule is the same. The packaging, the colour of the liquid or the labelling may look different — this is usually expected. Tell your team if you notice a change, so they can confirm what changed and why. Do not delay or stop treatment on the basis of a brand change without first speaking to your oncologist.
Do all cancer biologics have a biosimilar version?
No. A biosimilar can only exist once the patent on the reference biological medicine has expired, and not all biologics have reached that point yet. Even where a patent has expired, developing a biosimilar requires significant clinical data, so not every molecule has one. Your oncologist will know whether a biosimilar exists and has been approved by CDSCO for the specific medicine and indication in your treatment plan.
Why does the same medicine cost different amounts at different hospitals?
Hospitals negotiate bulk procurement prices that are not always passed on to patients in the same way. Some facilities charge a mark-up on procurement cost; others include medicines within a bundled day-care fee. The NPPA sets ceiling retail prices for scheduled medicines, which gives a public reference point. If cost concerns you, ask for an itemised breakdown and check the medicine's NPPA ceiling price — the NPPA website publishes current figures.
Explore 74 more Chemotherapy and Supportive Medicines by Name topics
HUB — Generic, Branded and Biosimilar Chemotherapy in India
Chemotherapy Drugs by Name
- 5-Fluorouracil (5-FU, Fluracil): What to Expect
- Bleomycin (Bleocip): What to Expect
- Capecitabine (Xeloda, Capegard, Xabine): The Tablet Form
- Carboplatin (Carboplat, Kemocarb): What to Expect
- Chemotherapy Drug Classes Explained
- Chemotherapy Drug Cost by Name
- Chemotherapy Drugs: A Complete Guide by Name
- Cisplatin (Cisplan, Kemoplat): What to Expect
- Cyclophosphamide (Endoxan, Cycloxan): What to Expect
- Cytarabine (Cytosar): What to Expect
- Docetaxel (Taxotere, Docetax, Daxotel): What to Expect
- Doxorubicin (Adrim, Adriamycin): The Red Injection
- Epirubicin: What to Expect
- Etoposide (Etosid, Fytosid): What to Expect
- Gemcitabine (Gemcite, Gemtaz, Oncogem): What to Expect
- Ifosfamide (Holoxan) and Mesna: Why They Go Together
- Irinotecan (Irinotel): What to Expect
- Liposomal Doxorubicin (Lipodox, Caelyx): How It Differs
- Methotrexate (Folitrax): What to Expect
- Mitomycin, Actinomycin and Less Common Agents
- Nab-Paclitaxel (Abraxane, Nabtaxel): How It Differs
- Oxaliplatin (Oxaliplat, Dacotin): What to Expect
- Paclitaxel (Paclitax, Intaxel, Oncotaxel): What to Expect
- Pemetrexed (Alimta, Pemgem, Pemnat): What to Expect
- Reading Your Chemotherapy Chart
- Temozolomide (Temodal, Temoget): The Brain Tumour Tablet
- Vincristine (Cytocristin, Oncovin): What to Expect
- Vinorelbine (Navelbine): What to Expect
- Which Drugs Affect Fertility?
- Which Drugs Affect the Heart, Kidneys or Lungs?
- Which Drugs Cause Hair Loss and Which Do Not?
- Which Drugs Cause Nausea and How Much?
- Which Drugs Cause Neuropathy?
- Why Was This Particular Drug Chosen for Me?
Drug Interactions, TB & Chronic Medicines
Generic, Branded & Biosimilar Chemotherapy in India
- Amrit Pharmacy and Subsidised Cancer Drugs
- Biosimilars: Quality, Regulation and Price
- Can You Buy Chemotherapy Drugs Yourself?
- Cold Chain and Drug Storage: Why It Matters
- Counterfeit and Substandard Cancer Drugs
- Generic vs Branded Chemotherapy in India
- How to Check a Chemotherapy Drug Is Approved
- Is Generic Chemotherapy Safe?
- Jan Aushadhi and Government Pharmacy Options
- Patient Assistance Programmes for Cancer Drugs
- Price Control on Cancer Drugs in India
- Questions to Ask About the Drugs You Are Given
- Rituximab Biosimilars in India
- Trastuzumab Biosimilars in India
- Who Chooses the Brand Used for Your Treatment?
- Why the Same Drug Costs Ten Times More
HUB — Chemotherapy Drugs by Name
HUB — Supportive Medicines Used With Chemotherapy
Supportive Medicines by Name
- Acid Blockers (Pantocid, Rantac) During Chemotherapy
- Allopurinol and Tumour Lysis Prevention
- Antibiotics and Antifungals During Chemotherapy
- Aprepitant (Aprecap, Emend) for Delayed Nausea
- Ayurvedic and Herbal Medicines Alongside Chemotherapy
- Cost of Supportive Medicines Across a Course
- Dexamethasone (Dexona) During Chemotherapy
- Emeset and Ondansetron for Chemotherapy Nausea
- Erythropoietin Injections for Low Haemoglobin
- Filgrastim (Grafeel, Neukine) Injections for Low Counts
- Leucovorin: Rescue and Modulation
- Long-Acting Growth Factor (Peg-Grafeel, Neulastim)
- Loperamide (Eldoper) for Chemotherapy Diarrhoea
- Mesna: Protecting the Bladder
- Mouthwashes and Mouth Care Medicines
- Painkillers That Are Safe During Chemotherapy
- Palonosetron and Longer-Acting Anti-Emetics
- The Medicines You Go Home With After Chemotherapy
- Vitamins and Supplements During Chemotherapy
- Why You Must Not Take Paracetamol Before Checking Your Temperature
Frequently asked questions
Are generic chemotherapy medicines as effective as the branded originals?
A generic chemotherapy medicine meets the same bioequivalence standard as its branded original — it releases the active molecule into the body in a comparable way, and CDSCO requires this before granting approval. The clinical evidence that established a chemotherapy medicine's effectiveness was generated for the active molecule, not for a specific brand, so that evidence applies to any approved version. What varies between manufacturers is production consistency, not the science behind the medicine.
How much cheaper are generic chemotherapy medicines in India?
The price gap can be very large — in some cases a generic costs a small fraction of the branded originator's price for the same active molecule. The gap depends on the specific medicine, how many manufacturers compete in the Indian market, and whether the NPPA has set a ceiling price. Prices change and vary by source, so we do not quote specific figures here. The NPPA website publishes current ceiling prices for scheduled medicines and is the most reliable public reference.
What does the NPPA regulate, and does it cover all cancer medicines?
The NPPA sets ceiling prices for medicines on the National List of Essential Medicines (NLEM), which includes a number of chemotherapy agents. A ceiling price is the maximum a manufacturer can charge at retail. Not every cancer medicine is on the NLEM, so not every chemotherapy agent has a regulated ceiling. Medicines not on the list are subject to price monitoring under the Drugs (Prices Control) Order but have more flexibility in pricing.
Can I buy my chemotherapy medicines from a medical shop or online pharmacy?
Chemotherapy medicines are prescription-only and should be sourced through a licensed oncology pharmacy or the pharmacy associated with your treating facility. Buying independently raises questions about storage conditions, cold-chain integrity and authenticity that are difficult to verify outside a controlled supply chain. Some biological medicines require strict temperature management throughout; a break in that chain can affect the medicine before it reaches you.
What medicines and supplements should I tell my oncologist about?
Tell your oncologist and pharmacist about every medicine you are taking — prescription and over-the-counter, herbal preparations, supplements and traditional medicines. Some of these interact with chemotherapy in ways that are not always obvious from the label. This applies equally to generic versions of prescription medicines: tell the team which version you have and where it came from, especially if it was not dispensed by your treating facility. The team uses this to adjust dosing and watch for interactions.
How is a biosimilar tested before it is approved in India?
CDSCO's biosimilar guidelines require a stepwise approach. The manufacturer first shows analytical similarity to the reference biological product, then provides pharmacokinetic data, and then clinical safety and effect data. The amount of clinical evidence required depends on how much can be confirmed from the earlier steps. This is more demanding than the bioequivalence test used for small-molecule generics, which reflects the greater complexity of biological medicines. WHO and ESMO have both published biosimilar guidance that aligns broadly with CDSCO's approach.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.